Literature DB >> 17608887

Increasing generic drug use in Medicare Part D: the role of government.

Herb Kohl1, William H Shrank.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17608887     DOI： 10.1111/j.1532-5415.2007.01286.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  14 in total

1.  Impact of generic substitution decision support on electronic prescribing behavior.

Authors:  Shane P Stenner; Qingxia Chen; Kevin B Johnson
Journal:  J Am Med Inform Assoc       Date:  2010 Nov-Dec       Impact factor: 4.497

2.  Generic and therapeutic substitution: ethics meets health economics.

Authors:  Steven Simoens
Journal:  Int J Clin Pharm       Date:  2011-03-24

3.  A comparison of drug formularies and the potential for cost-savings.

Authors:  Andrea L Kjos; Jon C Schommer; Yingli Yuan
Journal:  Am Health Drug Benefits       Date:  2010-09

4.  Ticagrelor versus genotype-driven antiplatelet therapy for secondary prevention after acute coronary syndrome: a cost-effectiveness analysis.

Authors:  Daniel J Crespin; Jerome J Federspiel; Andrea K Biddle; Daniel E Jonas; Joseph S Rossi
Journal:  Value Health       Date:  2011-05-19       Impact factor: 5.725

5.  Variability in drug formularies and implications in decision support.

Authors:  Matthew J Stephens; John T Finnell; Linas Simonaitis; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

6.  Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use.

Authors:  William H Shrank; Margaret Stedman; Susan L Ettner; Dee DeLapp; June Dirstine; M Alan Brookhart; Michael A Fischer; Jerry Avorn; Steven M Asch
Journal:  J Gen Intern Med       Date:  2007-07-24       Impact factor: 5.128

7.  Rationale and design of the Study Assessing the Effect of Cardiovascular Medications Provided as Low-cost, Evidence-based Generic Samples (SAMPLES) trial.

Authors:  William H Shrank; Niteesh K Choudhry; Daniel H Solomon; Thomas M Snedden; Thomas H Lee; Robert J Glynn; Theresa V Brown; Caitlin Jolda; Michelle Spetman; Maurice Alan Brookhart; Sebastian Schneeweiss; Jerry Avorn
Journal:  Am Heart J       Date:  2009-02-11       Impact factor: 4.749

Review 8.  The experiences of implementing generic medicine policy in eight countries: A review and recommendations for a successful promotion of generic medicine use.

Authors:  Mohamed Azmi Hassali; Alian A Alrasheedy; Andrew McLachlan; Tuan Anh Nguyen; Saleh Karamah Al-Tamimi; Mohamed Izham Mohamed Ibrahim; Hisham Aljadhey
Journal:  Saudi Pharm J       Date:  2013-12-25       Impact factor: 4.330

Review 9.  Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

Authors:  Brian Godman; William Shrank; Bjorn Wettermark; Morten Andersen; Iain Bishop; Thomas Burkhardt; Kristina Garuolienè; Marija Kalaba; Ott Laius; Roberta Joppi; Catherine Sermet; Ulrich Schwabe; Inês Teixeira; F Cankat Tulunay; Kamila Wendykowska; Corinne Zara; Lars L Gustafsson
Journal:  Pharmaceuticals (Basel)       Date:  2010-08-05

10.  The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?

Authors:  Daniel M Hartung; Dennis N Bourdette; Sharia M Ahmed; Ruth H Whitham
Journal:  Neurology       Date:  2015-04-24       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.